文献速递男科与性医学

围手术期睾酮补充改善性腺功能减退兔模型前尿道成形术短期结局

Perioperative Testosterone Supplementation Improves Short-Term Outcomes of Anterior Urethroplasty in Hypogonadal Models: Insights From a Preclinical Rabbit Study.
PubMed 文献 · Urology · 2025-04-08

本研究在去势新西兰兔球部尿道端端吻合模型中评估围手术期不同剂量丙酸睾酮补充对手术结局的影响。结果显示,雄激素补充可显著增加尿道管径、尿道周径、雄激素受体和CD31表达,上调血管生成相关基因并抑制纤维化相关基因,从而改善性腺功能减退兔的球部尿道成形术短期结局,但长期效应和临床适用性有待进一步研究。

要点

  • 去势兔补充丙酸睾酮可增加尿道管径和尿道周径,改善尿道成形术结局。
  • 雄激素补充增强尿道周血管化,表现为CD31表达升高和血管生成基因上调。
  • 雄激素补充抑制短期纤维化相关基因表达,但长期效应和临床适用性需进一步验证。

核心结论

  • 围手术期雄激素补充可增加性腺功能减退兔球部尿道成形术后的尿道管径、增强尿道周血管化并抑制短期纤维化相关基因表达,从而改善手术结局。

研究设计与样本

  • 所有兔接受球部尿道端端吻合的尿道成形术,术后一个月处死,评估血浆睾酮水平、尿道造影、大体标本、组织病理学、免疫荧光和转录组图谱。

主要发现

  • 去势对照组血浆睾酮水平(5.88 ± 0.19 nmol/L)显著低于生理剂量组(7.56 ± 0.53 nmol/L)、超生理剂量组(8.98 ± 0.35 nmol/L)和未去势对照组(7.30 ± 0.29 nmol/L;P <.0001)。
  • 术后一个月,与去势对照组相比,雄激素补充组显著增加尿道管径、尿道周径、雄激素受体和CD31表达(P <.001)。
  • 转录组分析显示,雄激素补充组血管生成相关基因上调、纤维化相关基因受抑制,并调节炎症、增殖和代谢通路。

临床怎么用

  • 在性腺功能减退患者中,围手术期雄激素补充可能改善前尿道成形术的短期结局,但需进一步临床研究验证。

局限性

  • 本研究为临床前兔模型研究,长期效应和临床适用性有待进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether perioperative androgen supplementation could improve surgical outcomes of anterior urethroplasty, particularly in hypogonadal patients, we evaluated the effects and mechanisms of systemic androgen supplementation at different doses in a castrated New Zealand rabbit model of bulbar urethroplasty. METHODS: Fifteen castrated and five non-castrated adult male New Zealand rabbits were randomized into four groups: non-castrated control, castrated control (0 mg/kg), physiological dose (2.5 mg/kg), and supraphysiological dose (5 mg/kg) of testosterone propionate. All rabbits underwent bulbar urethroplasty via end-to-end anastomosis and were sacrificed one month postoperatively. Plasma testosterone levels, urethrograms, gross specimens, histopathological data, immunofluorescence, and transcriptomic profiles were assessed and compared among the groups. RESULTS: Plasma testosterone levels in the castrated control group (5.88 ± 0.19 nmol/L) were significantly lower than those in the physiological dose group (7.56 ± 0.53 nmol/L), supraphysiological dose group (8.98 ± 0.35 nmol/L), and non-castrated control group (7.30 ± 0.29 nmol/L; P <.0001). One month postoperatively, androgen supplementation significantly increased urethral lumen diameter, urethral circumference, androgen receptor, and CD31 expression compared to the castrated control group (P <.001). Transcriptomic analysis revealed upregulation of angiogenesis-related genes and suppression of fibrosis-related genes in the androgen-supplemented groups, along with modulation of inflammatory, proliferative, and metabolic pathways. CONCLUSION: Perioperative androgen supplementation increases urethral lumen diameter, enhances peri-urethral vascularization, and suppresses short-term fibrosis-related gene expression, thereby improving outcomes of bulbar urethroplasty in hypogonadal rabbits. However, the long-term effects and clinical applicability of systemic androgen supplementation warrant further investigation.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Xue J, Liu Y, Ye H, et al. Perioperative Testosterone Supplementation Improves Short-Term Outcomes of Anterior Urethroplasty in Hypogonadal Models: Insights From a Preclinical Rabbit Study. Urology. 2025. PMID: 40209999. doi:10.1016/j.urology.2025.04.016

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。